These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6901611)

  • 1. In vivo monoamine oxidase inhibition by d-amphetamine.
    Miller HH; Shore PA; Clarke DE
    Biochem Pharmacol; 1980 May; 29(10):1347-54. PubMed ID: 6901611
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Fuller RW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A benzo[a]quinolizine derivative with a neuroleptic-like action on cerebral monoamine turnover.
    Saner A; Pletscher A
    J Pharmacol Exp Ther; 1977 Dec; 203(3):556-63. PubMed ID: 21955
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism and efflux of [3H]dopamine in rat neostriatum: presynaptic origin of 3,4-[3H]dihydroxyphenylacetic acid.
    Cubeddu LX; Hoffmann IS; Ferrari GB
    J Pharmacol Exp Ther; 1979 May; 209(2):165-75. PubMed ID: 255152
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the effects of beta-phenylethylamine and d-amphetamine on rat isolated atria.
    Pesce G; Adler-Graschinsky E
    J Pharmacol Exp Ther; 1983 Oct; 227(1):205-14. PubMed ID: 6555238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mouse brain monoamine oxidase by (+)-amphetamine in vivo.
    Green AL; el Hait MA
    J Pharm Pharmacol; 1978 Apr; 30(4):262-3. PubMed ID: 24723
    [No Abstract]   [Full Text] [Related]  

  • 7. Brain microdialysis in rats: a technique to reveal competition in vivo between endogenous dopamine and moclobemide, a RIMA antidepressant.
    Colzi A; d'Agostini F; Cesura AM; Da Prada M
    Psychopharmacology (Berl); 1992; 106 Suppl():S17-20. PubMed ID: 1546133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine-depleting drugs.
    Carlsson A
    Pharmacol Ther B; 1975; 1(3):393-400. PubMed ID: 772709
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.
    Colzi A; D'Agostini F; Cesura AM; Borroni E; Da Prada M
    J Pharmacol Exp Ther; 1993 Apr; 265(1):103-11. PubMed ID: 8473998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of amfonelic acid, alpha-methyltyrosine, Ro 4-1284 and haloperidol pretreatment on the depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Fuller RW; Hemrick-Luecke SK
    Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):17-25. PubMed ID: 3873102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of potential antineoplastic agents XXVI: 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2H-benzo[a]2-quinolizinone derivatives.
    Popp FD; Watts RF
    J Pharm Sci; 1978 Jun; 67(6):871-3. PubMed ID: 248062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel electrochemical approach for prolonged measurement of absolute levels of extracellular dopamine in brain slices.
    Burrell MH; Atcherley CW; Heien ML; Lipski J
    ACS Chem Neurosci; 2015 Nov; 6(11):1802-12. PubMed ID: 26322962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of epinephrine in rat hypothalamus by Ro 4-1284: influence of pargyline and harmaline.
    Fuller RW; Hemrick-Luecke SK
    Brain Res Bull; 1980; 5(5):589-91. PubMed ID: 6903452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new approach to the assessment of the potency of reversible monoamine oxidase inhibitors in vivo, and its application to (+)-amphetamine, p-methoxyamphetamine and harmaline.
    Green AL; El Hait MA
    Biochem Pharmacol; 1980 Oct; 29(20):2781-9. PubMed ID: 6893669
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
    Ichikawa J; Meltzer HY
    Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innately hearing impaired Sprague-Dawley rats exhibit audiogenic seizure susceptibility following monoamine depletion.
    Reigel CE; Faingold CL
    Proc West Pharmacol Soc; 1993; 36():267-71. PubMed ID: 8378388
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancement of 5-hydroxytryptamine synthesis in brain by monamine-depleting drugs.
    Saner A; Pletscher A
    J Pharm Pharmacol; 1978 Feb; 30(2):115-7. PubMed ID: 24096
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro inhibition of monoamine oxidase types A and B by d- and l-amphetamine.
    Miller HH; Clarke DE
    Commun Psychopharmacol; 1978; 2(4):319-25. PubMed ID: 729356
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of monoamine oxidase inhibitors on the N-demethylation and hydrolysis of meperidine.
    Eade NR; Renton KW
    Biochem Pharmacol; 1970 Jul; 19(7):2243-50. PubMed ID: 5520372
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of the d- and l-isomers of amphetamine on uptake, release and catabolism of norepinephrine, dopamine and 5-hydroxytryptamine in several regions of rat brain.
    Holmes JC; Rutledge CO
    Biochem Pharmacol; 1976 Feb; 25(4):447-51. PubMed ID: 938573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.